bone giant cell tumor
bone giant cell tumor
Explore linked clinical trials. Standard reference: MONDO:00056749 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TRACP-5b for Diagnosis and Follow-up of Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Not stated | 2026-05-27 | NCT07609277 | |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, bone disorder, bone giant cell tumor, bone sarcoma, breast disorder, breast neoplasm, carcinoma, connective tissue neoplasm, dedifferentiated chondrosarcoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, giant cell tumor, gonadal disorder, histiocytoma, malignancy in giant cell tumor of bone, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, osteosarcoma, ovarian cancer, ovarian carcinosarcoma, ovarian disorder, poorly differentiated thyroid gland carcinoma, sarcoma, skin disorder, thyroid gland squamous cell carcinoma, thyroid gland undifferentiated (anaplastic) carcinoma, triple-negative breast carcinoma, undifferentiated high grade pleomorphic sarcoma of bone, undifferentiated pleomorphic sarcoma | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03449108 | |
| Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 3 | 2026-04-22 | NCT03295981 | |
| Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 4 | 2026-01-05 | NCT07315828 | |
| PROMIS and Mobility Evaluation in Sarcoma Patients | Alzheimer disease, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, brain disorder, central nervous system disorder, cognitive disorder, connective tissue neoplasm, dementia, giant cell tumor, neoplasm, nervous system disorder, neurodegenerative disease, psychiatric disorder, sarcoma, tauopathy | Recruiting | Not stated | 2025-11-13 | NCT07227961 | |
| Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Active, not recruiting | Phase 4 | 2025-10-01 | NCT04586660 | |
| Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-10-18 | NCT06647901 | |
| A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Not yet recruiting | Phase 3 | 2023-04-19 | NCT05813665 | |
| Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage | Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, bone giant cell tumor, connective tissue neoplasm, giant cell tumor, neoplasm | Recruiting | Phase 2 | 2023-03-15 | NCT05595603 |